E-LIB Suche - Ergebnisse für: Pieczykolan, J.

1

46O Preliminary results from a phase IA trial of selective ..:

Lugowska, I. ; Stanczak, A. ; Roszkowski, K....
ESMO Open. 8 (2023) 1 - p. 100904 , 2023

Link: https://doi.org/10.1016/..

2

Design and development of an innovative, safe, and highly p..:

Mituła, F. ; Równicki, M. ; Pieczykolan, J....
European Journal of Cancer. 174 (2022) - p. S90 , 2022

Link: https://doi.org/10.1016/..

3

CPL500036 – a novel inhibitor of phosphodiesterase 10A – at..:

Matłoka, M. ; Lenda, T. ; Biała, D....
Neuroscience Applied. 1 (2022) - p. 100839 , 2022

Link: https://doi.org/10.1016/..

4

P.0078 Inflammatory cytokine plasma levels correlation with..:

Matłoka, M. ; Gajos-Draus, A. ; Majkowska, I....
European Neuropsychopharmacology. 53 (2021) - p. S55-S56 , 2021

Link: https://doi.org/10.1016/..

5

P.105 The study of molecular changes induced by CPL500-036,..:

Gajos-Draus, A. ; Mulewski, K. ; Górka, M....
European Neuropsychopharmacology. 31 (2020) - p. S4-S5 , 2020

Link: https://doi.org/10.1016/..

6

Pharmacodynamics of S-ketamine and ketamine racemate in rat..:

Gajos-Draus, A. ; Janowska, S. ; Janicka, M....
European Neuropsychopharmacology. 29 (2019) - p. S536-S537 , 2019

Link: https://doi.org/10.1016/..

7

CPL-500-036-02 – novel and highly bioavailable PDE10A inhib..:

Pankiewicz, P. ; Janowska, S. ; Gajos-Draus, A....
European Neuropsychopharmacology. 29 (2019) - p. S539-S540 , 2019

Link: https://doi.org/10.1016/..

8

Pro-cognitive effects of a AHN-208, 5-HT6 receptor antagoni..:

Krawczyk, M. ; Hogendorf, A. ; Hogendorf, A....
European Neuropsychopharmacology. 29 (2019) - p. S148 , 2019

Link: https://doi.org/10.1016/..

9

135 AD-O64.3: IFN-γ–TRAIL fusion protein. Use of two indepe..:

Zerek, B. ; Pieczykolan, J.S. ; Pawlak, S.D....
European Journal of Cancer. 50 (2014) - p. 47 , 2014

Link: https://doi.org/10.1016/..

10

367 Induction of apoptosis and inhibition of angiogenesis b..:

Rozga, P. ; Zerek, B. ; Pieczykolan, A....
European Journal of Cancer. 50 (2014) - p. 118 , 2014

Link: https://doi.org/10.1016/..

11

467 Two in one – Delivery of apoptotic signal into cancer c..:

Pawlak, S.D. ; Zerek, B.M. ; Rozga, P.K....
European Journal of Cancer. 50 (2014) - p. 152-153 , 2014

Link: https://doi.org/10.1016/..

12

519 AD-O53.2 – novel biological anticancer therapeutic agen..:

Poleszak, K. ; Pieczykolan, J. ; Pawlak, S....
European Journal of Cancer. 50 (2014) - p. 169 , 2014

Link: https://doi.org/10.1016/..

13

92 Novel Chimeric TRAIL-Based Protein Overcomes Resistance ..:

Pieczykolan, J.S. ; Pawlak, S.D. ; Zerek, B....
European Journal of Cancer. 48 (2012) - p. 29 , 2012

Link: https://doi.org/10.1016/..

14

91 TRAIL\Apo2L-Smac\Diablo Fusion Molecule with High Cytoto..:

Pieczykolan, J.S. ; Pawlak, S.D. ; Rózga, P.K....
European Journal of Cancer. 48 (2012) - p. 29 , 2012

Link: https://doi.org/10.1016/..

15

Technical assistance on simplification of CLLD implementati..:

Krzyżanowska-Orlik, Anna ; Brzozowy, Andrzej ; Pniewska, Beata.. - 1st edition . , 2024

Link: https://op.europa.eu/pub..